Could Smart Watches And Phone Apps Detect Alzheimer’s Years Before Symptoms Present?

Investigational therapies are finally achieving some success in treating Alzheimer’s disease, but a cure is not yet in sight. Medtech now has a golden opportunity in pre-symptomatic detection, according to digital health tech research initiative, EDoN.

Smartwatch Patient and Doctor
• Source: Shutterstock

Alzheimer’s disease has long exasperated researchers and patients alike for its seeming impossibility to be treated, let alone cured. The pile of investigational therapies that once showed theoretical promise, but failed to translate this into clinical success, is ever-growing.

More from Europe

AI Adoption In Pathology Is Lagging: Funding And Clinical Standardization Needed

 

AI diagnostic biotech startup Owkin says AI adoption in digital pathology is slower than in radiology. In a new report, it identifies reimbursement structures and lack of funding and operational resources as barriers to faster adoption.

Medtechs Ponder Significance Of UK’s Elective Reform Plan

 
• By 

The UK government kicks off a big year for National Health Service reform with a plan for 17 new or expanded surgical hubs by June and greater reliance on Community Diagnostic Centres.

Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push, UK Pilots

In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb brings highlights from Deloitte’s 2025 Life Sciences Outlook Report with medtech leaders’ forecasting significant investments in AI/GenAI. Brian Bossetta talks about the US FDA’s newly formed Digital Health Advisory Committee. Elizabeth Orr highlights the pros and cons of penetration testing for cybersecurity and talks about the US FDA’s final guidance on pre-determined change control plans. Natasha Barrow highlights UK MHRA's AI Airlock Pilot program and MANIFEST.

Scotland’s Medtech Innovation Ecosystem On The Road To ‘Tipping Point’

 

Scotland has a strong foundation of medtech research, but to reach the ‘tipping point’ where it has gained critical startup mass, it must overcome funding challenges and foster corporate startup partnerships.

More from Geography

Digital Health Roundup: 2025 Will See More AI/GenAI Adoption In Medtech, FDA’s Digital Health Push, UK Pilots

In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb brings highlights from Deloitte’s 2025 Life Sciences Outlook Report with medtech leaders’ forecasting significant investments in AI/GenAI. Brian Bossetta talks about the US FDA’s newly formed Digital Health Advisory Committee. Elizabeth Orr highlights the pros and cons of penetration testing for cybersecurity and talks about the US FDA’s final guidance on pre-determined change control plans. Natasha Barrow highlights UK MHRA's AI Airlock Pilot program and MANIFEST.

Medtech 2025: Deregulation, Tariffs Anticipated From New US Administration

The incoming second Trump administration promises changes for medtech that include both the potential benefits of deregulation and the risks of tariffs. See what a dozen-plus industry experts had to say.

Device Firms Should Prepare For New Recall Policies, Australia’s TGA Says

 

The Therapeutic Goods Administration is advising companies to get up to speed with its new recall procedure, which is designed to improve the timeliness of recalls, alerts and corrections, and reduce regulatory burden for sponsors.